A citation-based method for searching scientific literature

Yao-Ming Wu, Chiung-Hui Liu, Rey-Heng Hu, Miao-Juei Huang, Jian-Jr Lee, Chi-Hau Chen, John Huang, Hong-Shiee Lai, Po-Huang Lee, Wen-Ming Hsu, Hsiu-Chin Huang, Min-Chuan Huang. Cancer Res 2011
Times Cited: 76







List of co-cited articles
652 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
474
38

Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri. Cancer Res 2010
125
36

GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Mei-Chun Lin, Miao-Juei Huang, Chiung-Hui Liu, Tsung-Lin Yang, Min-Chuan Huang. Oral Oncol 2014
60
38

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
433
28

All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Kelly G Ten Hagen, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2003
348
26

Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
K Taniuchi, R L Cerny, A Tanouchi, K Kohno, N Kotani, K Honke, T Saibara, M A Hollingsworth. Oncogene 2011
62
29

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling.
Miao-Juei Huang, Rey-Heng Hu, Chih-Hsing Chou, Chia-Lang Hsu, Ya-Wen Liu, John Huang, Ji-Shiang Hung, I-Rue Lai, Hsueh-Fen Juan, Sung-Liang Yu,[...]. Oncotarget 2015
31
54

The sweet and sour of cancer: glycans as novel therapeutic targets.
Mark M Fuster, Jeffrey D Esko. Nat Rev Cancer 2005
920
21

Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
Jae-Hyun Park, Toyomasa Katagiri, Suyoun Chung, Kyoko Kijima, Yusuke Nakamura. Neoplasia 2011
75
21


Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
Z Li, S Yamada, S Inenaga, T Imamura, Y Wu, K-Y Wang, S Shimajiri, R Nakano, H Izumi, K Kohno,[...]. Br J Cancer 2011
59
25

Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation.
Shin-Yun Liu, Chia-Tung Shun, Kuan-Yu Hung, Hsueh-Fen Juan, Chia-Lang Hsu, Min-Chuan Huang, I-Rue Lai. Oncotarget 2016
27
55

Glycosylation defining cancer malignancy: new wine in an old bottle.
Senitiroh Hakomori. Proc Natl Acad Sci U S A 2002
717
18

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.
Avital Gaziel-Sovran, Miguel F Segura, Raffaella Di Micco, Mary K Collins, Douglas Hanniford, Eleazar Vega-Saenz de Miera, John F Rakus, John F Dankert, Shulian Shang, Robert S Kerbel,[...]. Cancer Cell 2011
263
18

GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.
Wan-Ling Ho, Chih-Hsing Chou, Yung-Ming Jeng, Meng-Yao Lu, Yung-Li Yang, Shiann-Tarng Jou, Dong-Tsamn Lin, Hsiu-Hao Chang, Kai-Hsin Lin, Wen-Ming Hsu,[...]. Oncotarget 2014
27
51

Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness.
David J Gill, Keit Min Tham, Joanne Chia, Shyi Chyi Wang, Catharina Steentoft, Henrik Clausen, Emilie A Bard-Chapeau, Frederic A Bard. Proc Natl Acad Sci U S A 2013
130
17


Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.
S Kitada, S Yamada, A Kuma, S Ouchi, T Tasaki, A Nabeshima, H Noguchi, K-Y Wang, S Shimajiri, R Nakano,[...]. Br J Cancer 2013
55
21

Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
Catharina Steentoft, Sergey Y Vakhrushev, Hiren J Joshi, Yun Kong, Malene B Vester-Christensen, Katrine T-B G Schjoldager, Kirstine Lavrsen, Sally Dabelsteen, Nis B Pedersen, Lara Marcos-Silva,[...]. EMBO J 2013
771
15

C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
Yao-Ming Wu, Chiung-Hui Liu, Miao-Juei Huang, Hong-Shiee Lai, Po-Huang Lee, Rey-Heng Hu, Min-Chuan Huang. Cancer Res 2013
52
23

Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis. Nat Rev Cancer 2015
15

Mucin-type O-glycosylation and its potential use in drug and vaccine development.
Mads Agervig Tarp, Henrik Clausen. Biochim Biophys Acta 2008
211
14

Pathways of O-glycan biosynthesis in cancer cells.
I Brockhausen. Biochim Biophys Acta 1999
410
14


Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Zhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli, Dimcho Bachvarov. Oncotarget 2014
62
17

The Tn antigen-structural simplicity and biological complexity.
Tongzhong Ju, Vivianne I Otto, Richard D Cummings. Angew Chem Int Ed Engl 2011
209
13

Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.
Koji Onitsuka, Kazunori Shibao, Yoshifumi Nakayama, Noritaka Minagawa, Keiji Hirata, Hiroto Izumi, Ken-ichi Matsuo, Naoki Nagata, Kenji Kitazato, Kimitoshi Kohno,[...]. Cancer Sci 2003
34
29

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers.
H Dosaka-Akita, I Kinoshita, K Yamazaki, H Izumi, T Itoh, H Katoh, M Nishimura, K Matsuo, Y Yamada, K Kohno. Br J Cancer 2002
36
27

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng,[...]. BMC Cancer 2010
48
18


Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer.
Dong Hua, Li Shen, Lan Xu, Zhi Jiang, Yinghui Zhou, Aihuan Yue, Shitao Zou, Zhihong Cheng, Shiliang Wu. Int J Mol Med 2012
25
36

Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
Shinji Yamamoto, Shoji Nakamori, Masanori Tsujie, Yuji Takahashi, Hiroaki Nagano, Keizo Dono, Koji Umeshita, Masato Sakon, Yasuhiko Tomita, Yoshihiko Hoshida,[...]. Pathobiology 2004
31
29

Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
Leonardo Freire-de-Lima, Kirill Gelfenbeyn, Yao Ding, Ulla Mandel, Henrik Clausen, Kazuko Handa, Sen-Itiroh Hakomori. Proc Natl Acad Sci U S A 2011
88
10

Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice.
Jianxin Fu, Holger Gerhardt, J Michael McDaniel, Baoyun Xia, Xiaowei Liu, Lacramioara Ivanciu, Annelii Ny, Karlien Hermans, Robert Silasi-Mansat, Samuel McGee,[...]. J Clin Invest 2008
171
10

Cloning and expression of human core 1 beta1,3-galactosyltransferase.
Tongzhong Ju, Kevin Brewer, Anil D'Souza, Richard D Cummings, William M Canfield. J Biol Chem 2002
208
10

ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Nora Berois, Etienne Blanc, Hugues Ripoche, Xénia Mergui, Felipe Trajtenberg, Sabrina Cantais, Michel Barrois, Philippe Dessen, Bertil Kågedal, Jean Bénard,[...]. Clin Chem 2006
30
26

Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines.
Catharina Steentoft, Sergey Y Vakhrushev, Malene B Vester-Christensen, Katrine T-B G Schjoldager, Yun Kong, Eric Paul Bennett, Ulla Mandel, Hans Wandall, Steven B Levery, Henrik Clausen. Nat Methods 2011
248
10


Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
Tongzhong Ju, Grainger S Lanneau, Tripti Gautam, Yingchun Wang, Baoyun Xia, Sean R Stowell, Margaret T Willard, Wenyi Wang, Jonathan Y Xia, Rosemary E Zuna,[...]. Cancer Res 2008
182
10

GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Tian Huanna, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, Jiao Manjing, Cao Wenjing, Qin Shaochuan,[...]. Mol Carcinog 2015
45
17

Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.
Adriaan G Holleboom, Helen Karlsson, Ruei-Shiuan Lin, Thomas M Beres, Jeroen A Sierts, Daniel S Herman, Erik S G Stroes, Johannes M Aerts, John J P Kastelein, Mohammad M Motazacker,[...]. Cell Metab 2011
75
9

Regulation of protein O-glycosylation by the endoplasmic reticulum-localized molecular chaperone Cosmc.
Tongzhong Ju, Rajindra P Aryal, Caleb J Stowell, Richard D Cummings. J Cell Biol 2008
90
9

Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila.
Tilo Schwientek, Eric P Bennett, Carlos Flores, John Thacker, Martin Hollmann, Celso A Reis, Jane Behrens, Ulla Mandel, Birgit Keck, Mireille A Schäfer,[...]. J Biol Chem 2002
143
9

GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Nora Berois, Charles-Henry Gattolliat, Enrique Barrios, Laura Capandeguy, Sétha Douc-Rasy, Dominique Valteau-Couanet, Jean Bénard, Eduardo Osinaga. Clin Chem 2013
36
19

Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10.
Lamei Cheng, Kouichi Tachibana, Yan Zhang, Jian ming Guo, Kahori Kahori Tachibana, Akihiko Kameyama, Han Wang, Toru Hiruma, Hiroko Iwasaki, Akira Togayachi,[...]. FEBS Lett 2002
51
13

Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.
Kazunori Shibao, Hiroto Izumi, Yoshifumi Nakayama, Ryo Ohta, Naoki Nagata, Minoru Nomoto, Ken-ichi Matsuo, Yuji Yamada, Kenji Kitazato, Hideaki Itoh,[...]. Cancer 2002
62
11

UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
Nora Berois, Daniel Mazal, Luis Ubillos, Felipe Trajtenberg, André Nicolas, Xavier Sastre-Garau, Henri Magdelenat, Eduardo Osinaga. J Histochem Cytochem 2006
60
11

Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
Kishore Guda, Helen Moinova, Jian He, Oliver Jamison, Lakshmeswari Ravi, Leanna Natale, James Lutterbaugh, Earl Lawrence, Susan Lewis, James K V Willson,[...]. Proc Natl Acad Sci U S A 2009
106
9

Expression pattern of polypeptide N-acetylgalactosaminyltransferase-10 in gastric carcinoma.
Yuan Gao, Zhenhua Liu, Jinghua Feng, Qizhe Sun, Bao Zhang, Wenling Zheng, Wenli Ma. Oncol Lett 2013
14
50

Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.
Guangyu An, Bo Wei, Baoyun Xia, J Michael McDaniel, Tongzhong Ju, Richard D Cummings, Jonathan Braun, Lijun Xia. J Exp Med 2007
226
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.